11.76USD+2.57%Mkt Cap: 844.62M USDP/E: 10.24Last update: 2026-05-26
Omeros Corporation, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting immunologic diseases. The company's lead p…
Industry Peers
Biotechnology110.61BUSDP/E 25.8
105.81BDKKP/E 20.4
66.47BUSDP/E 15.5
46.56BEURP/E 30.5
43.89BEURP/E 36.5
39.41BUSDP/E 74.0
32.84BUSD—
32.05BSEKP/E 47.4
Indicators:|
Key Statistics
Company
Market Cap844.62M USD
Enterprise Value956.90M USD
Revenue (TTM)9.89M USD
Gross Profit-18.84M USD
Net Income (TTM)-3.35M USD
Revenue/Share0.1480 USD
Last Price11.76 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees175
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS6821431029
Valuation
P/E (Trailing)10.24
P/E (Forward)22.15
PEG0.81
EV/EBITDA-9.17
EV/Revenue96.72
P/S87.50
P/B-7.07
EPS (TTM)1.14
EPS (Forward)0.54
52W Range
2.95060% of range17.65
52W High17.65 USD
52W Low2.950 USD
Profitability
Gross Margin-190.49%
Oper. Margin-176.09%
EBITDA Margin0.00%
Profit Margin871.02%
ROE2.76%
ROA-1.03%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-116.09M USD
CapEx (TTM)65.00K USD
FCF Margin1829.74%
FCF Yield21.43%
Net Debt91.29M USD
Net Debt/EBITDA-0.87
Balance Sheet
Debt/Equity-1.97
Current Ratio3.03
Quick Ratio2.48
Book Value/Sh-1.6910 USD
Cash/Share1.870 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.0 (Buy)
Target (Mean)33.50 USD
Target Range27.00 USD – 40.00 USD
# Analysts2
Ownership
Shares Out.72.38M
Float69.80M
Insiders3.56%
Institutions44.41%
Short Interest
Short Ratio11.7d
Short % Float22.69%
Short % Out.21.88%
Shares Short15.79M
Short (prev mo.)17.07M
Technical
SMA 5012.44 (-5.5%)
SMA 2009.532 (+23.3%)
Beta2.66
S&P 52W Chg28.31%
Avg Vol (30d)1.31M
Avg Vol (10d)1.74M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—